| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.7M | -79.8% |
| Cost of Revenue | $149K | -58.0% |
| R&D Expense | $18.6M | -10.8% |
| SG&A Expense | $11.8M | -0.5% |
| Operating Income | -$28.9M | -16.3% |
| Net Income | -$34.4M | -5.7% |
| EPS (Basic) | -$0.47 | +11.3% |
| EPS (Diluted) | -$0.47 | +11.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | -30.8% |
| Accounts Receivable | $507K | +198.2% |
| Current Assets | $21.3M | -29.4% |
| Total Assets | $25.1M | -26.1% |
| Current Liabilities | $4.8M | -29.6% |
| Total Liabilities | $64.0M | +28.1% |
| Stockholders' Equity | -$38.9M | -144.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.7M | -36.2% |
| Capital Expenditures | $977K | -45.0% |
| Investing Cash Flow | -$638K | +64.1% |
| Financing Cash Flow | $16.4M | +3870.0% |
| Free Cash Flow | -$25.7M | -28.9% |